Tschöpe, Carsten <br/><br/>
Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.  [electronic resource] 

 -  International immunopharmacology  Mar 2003 
 - 335-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1567-5769 
<br/><br/><label>Standard No.: </label>10.1016/S1567-5769(02)00273-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--biosynthesis<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Blood Pressure--drug effects<br/>Bradykinin--analogs & derivatives<br/>Bradykinin B2 Receptor Antagonists<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetic Nephropathies--complications<br/>Hypertension, Renal--complications<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Kallikrein-Kinin System--physiology<br/>Kidney Cortex--drug effects<br/>Kidney Function Tests<br/>Kininogens--biosynthesis<br/>Kinins--physiology<br/>Male<br/>Neprilysin--metabolism<br/>Peptidyl-Dipeptidase A--metabolism<br/>Proteinuria--drug therapy<br/>Ramipril--therapeutic use<br/>Rats<br/>Rats, Wistar